Your browser doesn't support javascript.
loading
Identifying Human Specific Adverse Outcome Pathways of Per- and Polyfluoroalkyl Substances Using Liver-Chimeric Humanized Mice.
Robarts, Dakota R; Paine-Cabrera, Diego; Kotulkar, Manasi; Venneman, Kaitlyn K; Gunewardena, Sumedha; Corton, J Christopher; Lau, Christopher; Foquet, Lander; Bial, Greg; Apte, Udayan.
Afiliação
  • Robarts DR; Department of Pharmacology, Toxicology, and Therapeutics, University of Kansas Medical Center, Kansas City, KS.
  • Paine-Cabrera D; Department of Pharmacology, Toxicology, and Therapeutics, University of Kansas Medical Center, Kansas City, KS.
  • Kotulkar M; Department of Pharmacology, Toxicology, and Therapeutics, University of Kansas Medical Center, Kansas City, KS.
  • Venneman KK; Department of Pharmacology, Toxicology, and Therapeutics, University of Kansas Medical Center, Kansas City, KS.
  • Gunewardena S; Department of Molecular and Integrative Physiology, University of Kansas Medical Center, Kansas City, KS.
  • Corton JC; Center for Computational Toxicology and Exposure, Office of Research and Development, U.S. EPA, Research Triangle Park, NC.
  • Lau C; Center for Public Health and Environmental Assessment, Office of Research and Development, US EPA, Research Triangle Park, NC.
  • Foquet L; Yecuris Corporation, Tualatin, OR.
  • Bial G; Yecuris Corporation, Tualatin, OR.
  • Apte U; Department of Pharmacology, Toxicology, and Therapeutics, University of Kansas Medical Center, Kansas City, KS.
bioRxiv ; 2023 Feb 03.
Article em En | MEDLINE | ID: mdl-36778348

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article